About Us
Beijing Advanced Medical Technologies, Ltd. Inc (AMET) is a medical device company founded in 2011. The company is headquartered in the Zhongguancun Biomedical Park in the Daxing District of Beijing, China.
AMET develops and manufactures fully bioresorbable coronary stents (AMSorb®) and peripheral stents (PeriSorb®) by using its proprietary Multi-Axial Scaffold Extrusion (MASE) technology, which has such advantages over the traditional laser cutting technology in producing bioresorbable vascular stents (BRS) as better efficiency and lower cost. With its two R&D products AMSorb® and PeriSorb® already in the advanced stages of clinical trials in China, AMET is set to revolutionize the manufacturing and use of bioresorbable stents in the medical device industry for the treatment of cardiovascular diseases.